ARYX (ARYx Therapeutics) ROE % Adjusted to Book Value: 0.00% (As of Sep. 2010)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ARYx Therapeutics ROE % Adjusted to Book Value?

ARYx Therapeutics ARYX -99.80% ROE % Adjusted to Book Value is 0.00% as of Sep. 2010.

ARYx Therapeutics's ROE % for the quarter that ended in Sep. 2010 was 0.00%. ARYx Therapeutics's PB Ratio for the quarter that ended in Sep. 2010 was N/A. ARYx Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2010 was N/A.

ARYx Therapeutics ROE % Adjusted to Book Value Related Terms

ARYx Therapeutics ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for ARYx Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYx Therapeutics ROE % Adjusted to Book Value Chart

ARYx Therapeutics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 0.00 -34.42 0.00

ARYx Therapeutics Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.30 0.00 0.00 0.00 0.00

ARYX vs YBAO, HPMM, BKIT: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ARYx Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ARYx Therapeutics ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ARYx Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ARYx Therapeutics's ROE % Adjusted to Book Value falls into.


ARYx Therapeutics ROE % Adjusted to Book Value Calculation

ARYx Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2009 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-270.76% / N/A
=N/A

ARYx Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2010 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
ARYx Therapeutics (ARYX) has a ROE % Adjusted to Book Value of 0.00% as of Sep. 2010. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on ARYx Therapeutics and its competitors.
Is ARYx Therapeutics' ROE % Adjusted to Book Value too high?
ARYx Therapeutics' current ROE % Adjusted to Book Value is 0.00%.
How does ARYx Therapeutics' ROE % Adjusted to Book Value compare to YBAO and HPMM?
ARYx Therapeutics' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on ARYx Therapeutics and its competitors. ARYx Therapeutics's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARYx Therapeutics stock overvalued right now?
ARYx Therapeutics (ARYX) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For ARYx Therapeutics (ARYX), the current ROE % Adjusted to Book Value is 0.00% as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARYx Therapeutics Business Description

Address 6300 Dumbarton Circle, Fremont, CA, USA, 94555
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.